MAPT and Alzheimer disease: Instead, we revealed in individuals post‐acute COVID‐19 prolonged glia activation and neuroinflammation, two other important drivers of tau hyperphosphorylation in the development of AD (Chen & Yu, 2023; van der Kant et al., 2020).